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Most organisms exhibit daily changes in physiology and metabolism under the control of a cell-autonomous
circadian clock. In the core clock mechanism, clock genes form a transcription factor network to generate
circadian rhythms of gene expression. Clock protein phosphorylation and histone modifications are also
important for the clock regulation. Pharmacological approaches have been making significant contribu-
tions to the clock research, for example, in characterizing the roles of protein kinases CKId, CKI3, CK2,
and GSK-3b. Recently, high-throughput circadian functional assays have been established. Chemical
biology approaches utilizing high-throughput compound screening together with RNAi-based genomic
screening will open a new way for the circadian clock field. Finding a set of compounds that potently affect
the clock function will lead to the identification of novel clock components and form the basis for therapeutic
strategies directed toward circadian disorders.Organization of Circadian Rhythms
in Mammals
The circadian clock controls daily rhythms
in a variety of physiological processes
such as sleep/wake, body temperature,
hormone secretion, and metabolism
(Hastings et al., 2003; Green et al., 2008;
Takahashi et al., 2008; Eckel-Mahan and
Sassone-Corsi, 2009). The identification
of clock-controlled processes is expand-
ing and includes hematopoietic stem cell
release (Mendez-Ferrer et al., 2008) and
blood levels of hundreds of metabolites
(Minami et al., 2009). Many of the rhythms
persist even under constant conditions in
the absence of any external time cues.
Importantly, the intrinsic period length of
the rhythms is strictly regulated by the
circadian clock mechanism, and pertur-
bation of clock function results in a change
in period length. To synchronize with
ambient 24 hr cycles, the clock has an
ability to adjust its phase in response to
environmental time cues primarily through
light (Guler et al., 2008; Hatori et al., 2008).
The circadian clock mechanism resides
at the cellular level, and single cells exhibit
circadian rhythms in a cell-autonomous
manner (Nagoshi et al., 2005; Welsh
et al., 2005). These cellular oscillators
are organized in a hierarchy, in which
the suprachiasmatic nucleus (SCN),
located in brain, constitutes the central
circadian pacemaker controlling behav-ioral rhythms (Hastings et al., 2003; Liu
et al., 2007a; Takahashi et al., 2008).
In contrast, peripheral clocks in other
tissues control local rhythmic outputs
such as retinal visual processing, hepatic
glucose regulation, and vascular regula-
tion of blood pressure and heart rate
(Storch et al., 2007; Lamia et al., 2008;
Wang et al., 2008). Within the SCN, the
cellular clocks are synchronized to form
a coherent oscillator through intercellular
coupling, making the SCN clock more
robust against genetic and environmental
perturbations than peripheral clocks (Liu
et al., 2007b).
Transcription Factor Networks
of the Circadian Clock
More than a dozen transcription factors
and modulators constitute transcriptional
feedback loops in the mammalian circa-
dian clock mechanism (Figure 1A) (Re-
ppert and Weaver, 2002; Gachon et al.,
2006; Liu et al., 2008; Takahashi et al.,
2008). In brief, bHLH-PAS proteins
CLOCK (or its homolog NPAS2) and
BMAL1 activate transcription of Per and
Cry genes, and PER and CRY proteins
(PER1, PER2, CRY1, and CRY2), in turn,
inhibit their own transcription. This core
loop is connected to two interlocking
loops composed of bZIP proteins (DBP,
TEF, HLF, and E4BP4) and nuclear
hormone receptors (REV-ERBa, REV-Chemistry & Biology 16, September 25, 200ERBb, RORa, RORb, and RORc). These
factors act in a combinatorial manner on
their three cognate cis-acting elements
(E box, D box, and RORE) to form
a network that generates robust rhythmic
gene expression (Ukai-Tadenuma et al.,
2008; Baggs et al., 2009). Importantly,
manyclockproteins bind tohistone-modi-
fying enzymes (Table 1), and histone acet-
ylation and methylation show circadian
rhythms on clock gene promoters (Etche-
garay et al., 2003, 2006; Curtis et al., 2004;
Naruse et al., 2004; Brown et al., 2005;
Ripperger and Schibler, 2006; Liu et al.,
2007c; Alenghat et al., 2008), providing
another essential layer of control.
In addition to transcriptional regulation,
posttranslational modifications of clock
proteins by phosphorylation, ubiquitina-
tion, and acetylation play important roles.
Most clock proteins undergo rhythmic
phosphorylation (Lee et al., 2001), and
many protein kinases are involved in the
clock mechanism (see below). Upon
phosphorylation of PER proteins, F box
proteins b-TrCP1 and b-TrCP2 lead to
regulated PER degradation thorough
the ubiquitin-proteasome pathway that
affects period regulation (Eide et al.,
2005; Shirogane et al., 2005; Reischl
et al., 2007; Maier et al., 2009). Another
F box protein, Fbxl3, causes proteasomal
degradation of CRY proteins, and mice
harboring a missense mutation of the9 ª2009 Elsevier Ltd All rights reserved 921
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period phenotype (Busino
et al., 2007; Godinho et al.,
2007; Siepka et al., 2007).
Acetylation of BMAL1 is
regulated by CLOCK and
SIRT1 and is necessary for
normal clock oscillation (Hir-
ayama et al., 2007; Nakahata
et al., 2008). SIRT1 also
deacetylates PER2 to facili-
tate proteasomal degrada-
tion (Asher et al., 2008).
Intriguingly, SIRT1 activity
is regulated by NAD+, and
the rate-limiting enzyme in
NAD+ biosynthesis (NAMPT)
is under circadian control
via a CLOCK-BMAL1-SIRT1
circuit, forming an inter-
locked transcriptional-enzy-
matic feedback loop (Naka-
hata et al., 2009; Ramsey
et al., 2009). cAMP signaling
also constitutes a novel feed-
back circuit: the trans-
cription-based loops drive
rhythms of cAMP signal-
ing, and dynamic changes
in cAMP signaling regulate
transcriptional output cycles
(O’Neill et al., 2008).
Pharmacological
Approaches for the
Circadian Clock
Mechanism
The application of well-char-
acterized compounds has
provided important insights
into the molecular mecha-
nism of the circadian clock.
Here, we summarize protein
kinase inhibitors that have
been extensively used (Table
2). Of note, the effectiveness
of a pharmacological ap-
proach is not only limited to
kinases. For example, a set
of pharmacological studies
identified the interlocking
loops of cAMP signaling and
NAD+ metabolism (O’Neill
et al., 2008; Nakahata et al.,
2009; Ramsey et al., 2009).
CKId and CKI3
Genetic and biochemical studies beauti-
fully indicated the role of CKId/3 in the
mammalian circadian clock. Hamster tau
mutants showing a short-period behav-
ioral rhythm have a missense mutation in
the CKI3 gene (Lowrey et al., 2000), and
human familial advanced sleep phase
syndrome (FASPS) with early
sleep times and early-morn-
ing awakening is attributed
to missense mutations of the
PER2 and CKId genes (Toh
et al., 2001; Xu et al., 2005).
Mouse models harboring
these mutations show a
similar short-period pheno-
type (Xu et al., 2007; Meng
et al., 2008). Molecularly,
CKId/3 phosphorylate PER
proteins, causing proteaso-
mal degradation, and tau
and FASPS mutations lead
to higher activity of PER
degradation than wild-type,
explaining the short-period
phenotype (Gallego et al.,
2006; Vanselow et al., 2006;
Meng et al., 2008).
The functional importance
of CKId/3 was successfully
supported by the known
CKId/3 inhibitors IC261, CKI-
7, and D4476, all of which
cause period lengthening in
cultured cells (Eide et al.,
2005; Vanselow et al., 2006;
Reischl et al., 2007; Hirota
et al., 2008). Furthermore, the
CKId/3 inhibitor PF-670462
and the CKI3-selective inhib-
itor PF-4800567 have re-
cently been developed, and
their effects on the circadian
period revealed a minimal
role of CKI3 and a much
more prominent role of CKId
in period regulation (Walton
et al., 2009). This finding is
consistent with a recent study
with CKId- and CKI3-deficient
mice (Etchegaray et al., 2009).
CK2
Our own compound screen-
ing strategy in human cells
(see below) identified a CK2
inhibitor, DRB, as a long-
period acting compound
(Hirota et al., 2008). Similarly,
another CK2 inhibitor, DMAT,
causes period lengthening
(Maier et al., 2009; Tsuchiya
et al., 2009). Moreover, RNAi-
based screening approaches have also
identified the role of CK2 in the regulation
of period length (Maier et al., 2009). These
observations are consistent with previous
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Figure 1. Mammalian Circadian Clock Mechanism and
High-Throughput Circadian Assay
(A) Transcription factor feedback loops of the mammalian circadian clock. In
the core loop, heterodimers of CLOCK (or NPAS2) and BMAL1 activate tran-
scription from the E box element, and PER and CRY proteins inhibit the activa-
tion. In addition, DBP (or TEF,HLF) activates andE4BP4 repressesDbox-medi-
ated regulation, and ROR proteins activate and REV-ERV proteins repress
RORE-mediated regulation, forming interlocking loops. These feedback loops
generate the rhythmic expression of not only clock genes, but also of output
genes to control the circadian changes in physiology and behavior.
(B) Circadian high-throughput screening of a compound library. A clonal
reporter cell line was established by using the circadian reporter Bmal1-dLuc
(top panel). Luminescence intensity of the reporter cells showed circadian
rhythm by reflecting Bmal1 promoter activity. The rhythm was monitored in
the presence of compounds (final 7 mM). One screening of the compound
library LOPAC contained four 384-well plates, and profiles of one 384-well
plate are represented in the bottom left panel. Each horizontal raster line repre-
sents a single well, and elapsed time is plotted to the right. Luminescence
intensity data from each well are normalized for amplitude, and then indicated
by gray scale: peak is white and trough is black. Red and blue arrowheads indi-
cate the positions of long- and short-period compounds, respectively. Note
that there are many compounds that change the phase of the rhythm without
affecting the period. Bottom right panels indicate representative traces for
a long-period compound (SP600125) and a short-period compound (Indiru-
bin-30-oxime).922 Chemistry & Biology 16, September 25, 2009 ª2009 Elsevier Ltd All rights reserved
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CrosstalkTable 1. Histone-Modifying Enzymes and Cofactors/Ligands Binding to Clock Proteins
Clock Proteins Binding Partners References
Histone Acetylation
CLOCK/NPAS2-BMAL1 p300/CBP and PCAF Etchegaray et al., 2003;
Curtis et al., 2004
CRY1 mSin3B and HDAC1/2 Naruse et al., 2004
REV-ERBa NCoR and HDAC3 Alenghat et al., 2008
RORa PGC-1a, p300, and GCN5 Liu et al., 2007c
Histone Methylation
CLOCK-BMAL1 EZH2 Etchegaray et al., 2006
PER1/2 WDR5 Brown et al., 2005
Cofactors/Ligands
CLOCK/NPAS2-BMAL1 NAD Rutter et al., 2001
NPAS2 Heme Dioum et al., 2002
PER2 Heme Kaasik and Lee, 2004
CRY1/2 FAD Hitomi et al., 2009
REB-ERBa/b Heme Raghuram et al., 2007;
Yin et al., 2007
RORa Choresterol derivative Kallen et al., 2002findings in Drosophila that decreased
activity of CK2 causes long-period behav-
ioral rhythms (Lin et al., 2002; Akten et al.,
2003). Further biochemical studies re-
vealed that CK2 phosphorylates PER2 to
regulate its stability (Maier et al., 2009;
Tsuchiya et al., 2009) and also phosphor-
ylates BMAL1 to regulate its nuclear
accumulation (Tamaru et al., 2009).
Importantly, PER2 and BMAL1 proteins
that have missense mutations at CK2-
phosphorylation sites cause abnormal
oscillation of the cellular clock, indicating
the importance of these modifications
(Maier et al., 2009; Tamaru et al., 2009;
Tsuchiya et al., 2009).
GSK-3b
Biochemical studies revealed thatGSK-3b
phosphorylates PER2 for nuclear localiza-
tion (Iitaka et al., 2005), CRY2 for protea-
somal degradation (Harada et al., 2005),
and REV-ERBa for stabilization (Yin et al.,
2006). Lithium has been proposed to act
through GSK-3 inhibition (Quiroz et al.,
2004), and it robustly lengthens the circa-
dianperiod inawide rangeof experimental
systems (Engelmann, 1987), suggesting
that GSK-3 inhibition causes period
lengthening. Consistently, reduction of
GSK-3 activity by genetic manipulation
causes period lengthening in Drosophila
(Martinek et al., 2001). However, our
chemical screening strategy identified
two compounds inhibiting both CDK and
GSK-3 (indirubin-30-oxime and kenpaul-
lone) as short-period compounds. Furtheranalyses with GSK-3-selective inhibitors
(Chir99021 and 1-azakenpaullone) and
RNAi-mediated knockdown revealed that
inhibition of GSK-3b clearly causes
a short-period phenotype in mammals
(Hirota et al., 2008). Similar period short-
eningwas observedwith newly developed
indirubin derivatives that selectively inhibit
GSK-3 (Vougogiannopoulou et al., 2008).
Because lithium affects inositol mono-
phosphatase and other phosphomonoes-
terases as well as GSK-3 (Quiroz et al.,
2004), the long-period phenotype in
mammals might be mediated by lithium-
targeted protein(s) other than GSK-3.
Identifying these additional targets is of
current interest in the field.
Other Kinases for Period Regulation
Pharmacological studies revealed that
a CDK inhibitor, roscovitine; a p38
MAPK inhibitor, SB203580; and a JNK
MAPK inhibitor, SP600125, cause period
lengthening in cultured Bulla eye (Krucher
et al., 1997), chicken pineal gland (Haya-
shi et al., 2003), and mouse SCN (Chan-
sard et al., 2007), respectively. Interest-
ingly, all of them (or the analog) were
identified as long-period compounds in
our screening with human cells (Hirota
et al., 2008). It should be noted that these
compounds possibly inhibit CKId/3 aswell
as their primary targets (Hasegawa and
Cahill, 2004; Fabian et al., 2005). Addi-
tional studies are necessary to clarify the
role of CDK, p38, and JNK in the molec-
ular clockwork.Chemistry & Biology 16, September 25, 2009Kinases for Phase Regulation
In addition to playing a role in period re-
gulation studies, pharmacological ap-
proaches identified the involvement of
kinases in the phase-shifting mechanism.
A MEK (ERK kinase) inhibitor, U0126,
attenuates light-dependent phase delays
and advances in the SCN (Butcher et al.,
2002; Coogan and Piggins, 2003) and
serum shock-mediated rhythm induction
in cultured fibroblasts (Akashi and Nish-
ida, 2000). Similarly, a CaMKII inhibitor,
KN-62, attenuates phase delays and
advances in the SCN (Golombek and
Ralph, 1994). KN-62 also inhibits light-
dependent activation of ERK, implicating
CaMKII as an upstream regulator of ERK
(Butcher et al., 2002). A PKG inhibitor,
KT5823, attenuates phase advances, but
not phase delays (Ding et al., 1998), sug-
gesting a time-of-day-specific function
for PKG. Intriguingly, PKGII-deficient
mice show impaired phase delays but
normal phase advances (Oster et al.,
2003), contrary to what was observed in
the pharmacological study. In cultured
fibroblasts, an ALK inhibitor, SB431542,
attenuates alkaline shock-induced phase
delays, and ALK-SMAD3-Dec1 signaling
was identified as a novel clock input
pathway (Kon et al., 2008).
High-Throughput Screening: A New
Avenue for the Circadian Assay
In addition to the individual approach with
a small number of compounds, compre-
hensive screening of compound libraries
will be effective in investigating themolec-
ular clock mechanism. Advances in cell-
based circadian assays and biolumines-
cence recording technology (Nagoshi
et al., 2005; Welsh et al., 2005) enabled
us to develop a high-throughput circadian
functional assay (Hirota et al., 2008). This
system consists of luminescent reporter
cells, screening automation, and a data
analysis pipeline.We utilized the circadian
luciferase reporter Bmal1-dLuc, which
expresses the rapidly degradable lucif-
erase under the control of Bmal1 gene
promoter (Liu et al., 2008), to monitor
circadian rhythms in cultured cells
(Figure 1B, top panel). The GNF Auto-
mated Compound Profiling System (Mel-
nick et al., 2006) was applied to record
the luminescence every 2 hr over the
course of 4 days. A unique aspect of the
circadian screening is that the phenotype
is not only a simple intensity change, butª2009 Elsevier Ltd All rights reserved 923
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Compounds Primary Targets Period Phenotypes Cell Types References
Phenotypes in
U2OS Cellsa
IC261 CKId/3 Long period Rat-1 fibroblasts Eide et al., 2005 Not tested
CKI-7 CKId/3 Long period NIH 3T3 fibroblasts Vanselow et al., 2006 Not tested
D4476 CKId/3 Long period NIH 3T3 fibroblasts Reischl et al., 2007 Long period
PF-670462 CKId/3 Long period Rat-1 fibroblasts Walton et al., 2009 Not tested
PF-4800567 CKI3 No change Rat-1 fibroblasts Walton et al., 2009 Not tested
DRB CK2 Long period Aplysia eye Raju et al., 1991 Long period
DMAT CK2 Long period U2OS cells;
NIH 3T3 fibroblasts
Maier et al., 2009;
Tsuchiya et al., 2009
Not tested
Indirubin-30-oxime CDK&GSK-3 Not tested Not tested Not tested Short period
Kenpaullone CDK&GSK-3 Short period Rat-1 fibroblasts Vougogiannopoulou et al., 2008 Short period
Chir99021 GSK-3 Not tested Not tested Not tested Short period
1-azakenpaullone GSK-3 Not tested Not tested Not tested Short period
Indirubin derivatives GSK-3 Short period Rat-1 fibroblasts Vougogiannopoulou et al., 2008 Not tested
Roscovitine CDK Long period Bulla eye Krucher et al., 1997 Long period
SB203580/SB202190 p38 Long period Chicken pineal gland Hayashi et al., 2003 Long period
SP600125 JNK Long period Mouse SCN Chansard et al., 2007 Long period
aHirota et al., 2008.also an alternation in a repeating cycle.
Because of this uniqueness, a specialized
algorithm is necessary for identifying
the ‘‘hits.’’ We developed a curve-fitting
program, CellulaRhythm, to calculate
rhythm parameters such as period length
from large amounts of luminescence data
of 384-well plate recordings. The program
can also visualize the luminescence
rhythms as traces and heat maps for
manual inspection of the validity of the
calculated parameters. A more sophisti-
cated software, MultiCycle (Actimetrics),
has recently been developed, and it works
in a manner similar to CellulaRhythm
for the circadian parameter estimation.
Between the parameters (period, phase,
amplitude, and damping rate) we focused
on the period, because a deficiency of the
core clock mechanism can be reflected to
an alternation of the period. A more
severe phenotype is arrhythmicity, but it
is difficult to differentiate from the effect
on the general health of the cells. Impor-
tantly, the period is the most robust
parameter, stemming from the repeating
characteristics of the clock.
The success of the screening may
depend on the robustness of the system.
Especially, the cellular rhythmicity is
a key factor for the circadian screening.
Among all cell lines tested, human U2OS
cells showed prominent and highly repro-
ducible rhythmicity even in a 384-well
format. In control (untreated) conditions,924 Chemistry & Biology 16, September 25,more than 97% of the wells are within
the period range of mean ± 0.5 hr. We
applied this system to further dissect the
circadian clock mechanism by using
a chemical biology approach. A structur-
ally diverse chemical library, LOPAC
(Library of Pharmacologically Active
Compounds), containing 1280 pharma-
cologically active compounds was initially
used to analyze the effect on the circadian
period length in human U2OS cells
(Figure 1B, bottom panels). We identified
11 compounds causing reproducible
period changes of R 0.5 hr. Among
them, 7 compounds are protein kinase
inhibitors/activators, including roscovi-
tine, SP600125, and SB202190 (an
analog of SB203580), previously known
to change the circadian period in other
organisms (Table 2). Importantly, the
period effects of indirubin-30-oxime, ken-
paullone, and DRB predicted the novel
roles of GSK-3b and CK2 in the mamma-
lian circadian clock mechanism (Table 2).
Together, these observations demon-
strate the validity of the high-throughput
circadian assay system and the effective-
ness of chemical biology in exploring
unidentified mechanisms of the circadian
clock.
Our group and others recently devel-
oped 96- or 384-well format high-
throughput circadian assays for RNAi-
based genomic screening (Hirota et al.,
2008; Vollmers et al., 2008; Maier et al.,2009 ª2009 Elsevier Ltd All rights reserved2009; Zhang et al., 2009). The screening
of RNAi libraries for human kinases sug-
gested the involvement of more than
22 kinases in the cellular clock mecha-
nism (Maier et al., 2009; Zhang et al.,
2009). For example, knockdown of
MAPK8 (JNK1) causes period lengthening
(Zhang et al., 2009), which is consistent
with the effect of a JNK inhibitor,
SP600125 (Chansard et al., 2007; Hirota
et al., 2008). A combination of genomic
approaches and additional screening of
kinase inhibitor libraries will likely reveal
novel roles for many kinases in the
mammalian clockworks.
Future Outlook of the Chemical
Biology Approach for the Circadian
Clock
In the screening of limited numbers of
well-characterized compounds, many of
the hits were related to the pathways
already known to affect the circadian
clock function. Therefore, it is interesting
to expand the circadian screening for
more comprehensive, large-scale com-
pound libraries containing hundreds of
thousands of compounds. A wide varia-
tion of chemical structures has the advan-
tage of probing many classes of potential
targets, which may include not only
kinases, but also other proteins such as
histone-modifying enzymes, metabolic
enzymes, and even clock proteins. An
attractive possibility of a chemical biology
Chemistry & Biology
Crosstalkapproach will be the identification of novel
clock components that cannot be easily
achieved by forward and reverse genetic
screens because of lethality, pleiotropy,
and functional overlapping of closely
related proteins. Although our high-
throughput compound screening ap-
proach is very powerful, there are several
important points to keep in mind. First,
generally, it is technically challenging to
identify proteins specifically affected by
the novel compound. In addition, com-
pounds (even well-characterized ones)
may have multiple targets that give rise
to the observed circadian effect. After
the identification of candidate proteins,
additional studies with other compounds
targeting the same protein(s) (if available)
and/or RNAi-mediated knockdown are
necessary. The confirmation of the phe-
notype by multiple reagents may lead to
the determination of the responsible
protein(s). Simultaneous knockdown of
multiple genes will be required if there is
functional overlap, and this approach
cannot be easily achieved in RNAi
screening, which targets each gene one
by one. Second, the phenotype may arise
not only from a direct effect on the clock,
but also from indirect effects such as
alterations of general transcription/trans-
lation and the overall health of the cells.
Although it is difficult to exclude the possi-
bility of indirect effects, biochemical
studies play important roles in exploring
the mechanism of direct effects. For
example, CK2 directly phosphorylates
clock proteins for rhythm regulation (Ma-
ier et al., 2009; Tamaru et al., 2009; Tsu-
chiya et al., 2009), besides it has a general
effect on cell health and transcription (St-
Denis and Litchfield, 2009). Third, there
are potential differences in the pheno-
types between different candidate cell
lines that can be used for screening.
Given that the majority of the genes
showing circadian expression are tissue
specific (Duffield, 2003), clock modifiers
could be cell type specific. Immortalized
cell lines may have aberrant signaling
pathways that possibly affect the circa-
dian phenotype. Thus far, however,
many of the period-changing compounds
are effective in a variety of cell types,
including primary cells and even other
organisms (Table 2). In contrast, a
phase-changing compound, dexametha-
sone, is effective in peripheral tissues,
but not in the SCN because of theabsence of glucocorticoid receptor (Bal-
salobre et al., 2000). Testing the effect of
compounds in the SCN and peripheral
tissues ex vivo as well as in vivo will
provide new opportunities for common
and tissue-specific clock mechanisms.
Taken together, chemical biology will
play an increasingly important role along
with genome-wide RNAi screening in dis-
secting the molecular mechanism of the
circadian clock.
Furthermore, compound screening will
generate novel proof-of-concept probes
for manipulating clock functions in a
dose-dependent and inducible manner.
Such proof-of-concept probes will pro-
vide the chemical starting points for the
identification of small-molecule therapeu-
tics designed for circadian disorders. For
example, a novel CKId/3 inhibitor might
be useful in treating the observed short-
period phenotype caused by FASPS and
tau mutations. Interestingly, many clock
proteins bind to cofactors or ligands
(Table 1) (Rutter et al., 2001; Dioum
et al., 2002; Kallen et al., 2002; Kaasik
and Lee, 2004; Raghuram et al., 2007;
Yin et al., 2007; Hitomi et al., 2009), and
CLOCK protein has an acetyltransferase
activity (Doi et al., 2006). Compounds
affecting these activities may alter circa-
dian clock function and can be used
as specific modulators of circadian
oscillations.
Chemistry & Biology invites your
comments on this topic. Please write
to the editors at chembiol@cell.com.
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